Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study

Structural and Functional Properties of Deep Abdominal Subcutaneous Adipose Tissue Explain Its Association With Insulin Resistance and Cardiovascular Risk in Men

(2013) Kyriakoula Marinou et al.   DIABETES CARE

The Relationship between Adipokines, Metabolic Parameters and Insulin Resistance in Patients with Metabolic Syndrome and Type 2 Diabetes

(2013) JM Lee et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity

(2013) Raffaella Cancello et al.   Obesity

Abdominal Superficial Subcutaneous Fat: A putative distinct protective fat subdepot in type 2 diabetes

(2012) R. Golan et al.   DIABETES CARE

Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue

(2012) J Lundbom et al.   INTERNATIONAL JOURNAL OF OBESITY

Structural and inflammatory heterogeneity in subcutaneous adipose tissue: Relation with liver histopathology in morbid obesity

(2012) Joan Tordjman et al.   JOURNAL OF HEPATOLOGY

Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113)

(2011) Karunakaran Indulekha et al.   CLINICAL BIOCHEMISTRY

Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study

(2009) Omer T. Njajou et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Visceral obesity and metabolic syndrome: two faces of the same medal?

(2009) Rosario Scaglione et al.   Internal and Emergency Medicine

Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity

(2009) Hongbo He et al.   Translational Research

Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels?

(2008) Rumi Fujikawa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride

(2008) Hataikarn Nimitphong et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects

(2008) Gillian E. Walker et al.   Obesity